"We found that during the 5-year study period, the total number of claims for vaginal estrogen, the number of prescribers, and the number of beneficiaries decreased," says Alexandra Tabakin, MD.
In this video, Alexandra Tabakin, MD, gives an overview of the Urogynecology paper “Vaginal Estrogen Prescribing and Cost Trends Among Medicare Part D Beneficiaries.” Tabakin is a fellow in female pelvic medicine and reconstructive surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.
This study was a claims-based analysis using the Medicare Part D Spending and Prescriber Datasets from 2016 to 2020. We evaluated prescribing cost trends of 4 low-dose vaginal estrogen products, including Estrace, Estring, Yuvafem, and Vagifem. We found that during the 5-year study period, the total number of claims for vaginal estrogen, the number of prescribers, and the number of beneficiaries decreased. The number of beneficiaries actually decreased by over 50%. Conversely, spending per vaginal estrogen claim and cost per beneficiary increased, and these findings are surprising given the aging population coupled with growing safety data and support from national organizations on the safety of vaginal estrogen.
This transcription was edited for clarity.
Study examines patient knowledge of urinary tract infections
July 11th 2024"The objective of this study was to assess baseline knowledge about urinary tract infections, interest in health resources, and platform preferences for health information acquisition and dissemination," says Stephanie Gleicher, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.
Study examines patient knowledge of urinary tract infections
July 11th 2024"The objective of this study was to assess baseline knowledge about urinary tract infections, interest in health resources, and platform preferences for health information acquisition and dissemination," says Stephanie Gleicher, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.
2 Commerce Drive
Cranbury, NJ 08512